Skip to main content
SpringerLink
Log in

Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

We have examined tumor progression and metastatic properties of three clonal murine mammary tumor cell lines of recent origin (D2A1, D2.OR and D2.1). These lines were derived from spontaneous mammary tumors which originated from a D2 hyperplastic alveolar nodule (HAN) line. D2A1 cells were more malignant than D2.OR or D2.1 cells, whether measured by experimental metastasis assays after intravenous injection in nude mice or chick embryos,in vivo growth rate of primary tumors following mammary fat pad injection in nude mice, or spontaneous metastasis assay from primary tumors growing in mammary fat pads. D2A1 cells also were more invasivein vitro in a Matrigel invasion assay than D2.1 cells, while the D2.OR cells were non-invasive in this assay. The increased invasiveness and malignancy of D2A1 cells were associated with increased levels of mRNA for the cysteine proteinase cathepsin L. Levels of osteopontin (OPN), nm23, int-1 and int-2 mRNAs were also examined. Nm23 levels were highest in the most malignant cell line. These cell lines provide a model for studying the tumorigenic and metastatic ability of mammary tumor cells and offer several advantages: they were cloned from mammary tumors that originate from a common source of preneoplastic cells (D2HAN); they are of relatively recent origin; and they have spontaneously arrived at different stages of tumor progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Vaage J, 1988, Metastasizing potentials of mouse mammary tumors and their metastases.International Journal of Cancer,41, 855–858.

    Google Scholar 

  2. Frost P, Kerbel R, Hunt B, Man S and Pathak S, 1987, Selection of metastatic variants with identifiable karyotypic changes from a nonmetastatic murine tumor after treatment with 2-deoxy-5-azacytidine or hydroxyurea: implications for the mechanisms of tumor progression.Cancer Research,47, 2690–2695.

    Google Scholar 

  3. Waghorne C, Kerbel RS and Breitman ML, 1987, Metastatic potential of SPl mouse mammary adenocarcinoma cells is differentially induced by activated and normal forms of c-H-ras.Oncogene,1, 149–155.

    Google Scholar 

  4. Miller F, McEachern D and Miller B, 1989, Growth regulation of mouse mammary tumor cells in collagen gel cultures by diffusible factors produced by normal mammary gland epithelium and stromal fibroblasts.Cancer Research,49, 6091–6097.

    Google Scholar 

  5. Rak JW, McEachern D and Miller FR, 1992, Sequential alteration of peanut agglutinin binding-glycoprotein expression during progression of murine mammary neoplasia.British Journal of Cancer,65, 641–648.

    Google Scholar 

  6. Harkness MN, Bern HA, Alfert M and Goldstein NO, 1957, Cytochemical studies of hyperplastic alveolar nodules in the mammary gland of the C3H/He CRGL mouse.Journal of the National Cancer Institute,19, 1023–1029.

    Google Scholar 

  7. Pitelka DR, Bern HA, Deome KB, Schooley CN and Wellings SR, 1958, Virus-like particles in hyperplastic alveolar nodules of the mammary gland of the C3H/He CRGL mouse.Journal of the National Cancer Institute,20, 541–553.

    Google Scholar 

  8. Pitelka DR, Deome KB and Bern HA, 1960, Virus-like particles in precancerous hyperplastic mammary tissues of C3H and C3Hf mice.Journal of the National Cancer Institute,25, 753–777.

    Google Scholar 

  9. Wellings SR, Deome KB and Pitelka DR, 1960, Electron microscopy of milk secretion in the mammary gland of the C3H/Crg1 mouse, 1. Cytomorphology of the prelacting and the lactating gland.Journal of the National Cancer Institute,25, 393–421.

    Google Scholar 

  10. Medina D. Preneoplastic lesions in mouse mammary tumorigenesis. In: Busch H, ed.Methods in Cancer Research, pp. 3–53. New York: Academic Press, 1973.

    Google Scholar 

  11. McGrath CM and Jones RF, 1978, Hormonal induction of mammary tumor viruses and its implications for carcinogenesis.Cancer Research,38, 4112–4125.

    Google Scholar 

  12. Cardiff RD, 1984, Protoneoplasia: the molecular biology of murine mammary hyperplasia.Advances in Cancer Research,42, 167–190.

    Google Scholar 

  13. Nusse R, Van Ooyen A, Cox D, Fung YKT and Varmus H, 1984, Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15.Nature,307, 131–136.

    Google Scholar 

  14. Peters G, Lee AE and Dickson C, 1984, Activation of cellular gene by mouse mammary tumor virus may occur early in mammary tumor development.Nature 309, 273–275.

    Google Scholar 

  15. Jackson DP, Percy DH and Morris VL, 1984, Characterization of murine hepatitis virus (JHM) RNA from rats with experimental encephalomyelitis.Virology,137, 297–304.

    Google Scholar 

  16. Tuck AB, Wilson SM, Khokha R and Chambers AF, 1991, Different patterns of gene expression in ras-resistant andras-sensitive cells.Journal of the National Cancer Institute,83, 485–491.

    Google Scholar 

  17. Hill RP, Chambers AF, Ling V and Harris JF, 1984, Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells.Science,224, 998–1001.

    Google Scholar 

  18. Chambers AF, Shafir R and Ling V, 1982, A model system for studying metastasis using the embryonic chick.Cancer Research,42, 4018–4025.

    Google Scholar 

  19. Chambers AF, Wilson SM, Tuck AB, Denhardt GH and Cairncross JG, 1990, Comparison of metastatic properties of a variety of mouse, rat, and human cells in assays in nude mice and chick embryos.In Vivo,4, 215–220.

    Google Scholar 

  20. Auffray C and Rougeon F, 1980, Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.European Journal of Biochemistry,107, 303–314.

    Google Scholar 

  21. Craig AM, Bowden GT, Chambers AF, Spearman MA, Greenberg AH, Wright JA, McLeod M and Denhardt DT, 1990, Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts.International Journal of Cancer,46, 133–137.

    Google Scholar 

  22. Denhardt DT, Hamilton RT, Parfett CLJ, Edwards DR, St Pierre R, Waterhouse P and Nilsen-Hamilton M, 1986, Close relationship of the major excreted protein of transformed murine fibroblasts to thiol-dependent cathepsins.Cancer Research,46, 4590–4593.

    Google Scholar 

  23. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA and Sobel ME, 1988, Evidence for a novel gene associated with low tumor metastatic potential.Journal of the National Cancer Institute,80, 200–204.

    Google Scholar 

  24. Cohen JC, Shank PR, Morris VL, Cardiff R and Varmus HE, 1979, Integration of the DNA of mouse mammary tumor virus in virus-infected normal and neoplastic tissues of the mouse.Cell,16, 333–345.

    Google Scholar 

  25. Minty AJ, Alonso S, Guenet J-L and Buckingham ME, 1983, Number and organization of actin-related sequences in the mouse genome.Journal of Molecular Biology,167, 77–101.

    Google Scholar 

  26. Miller FR, Medina D and Heppner GH, 1981, Preferential growth of mammary tumors in intact mammary fat pads.Cancer Research,41, 3863–3867.

    Google Scholar 

  27. Miller FR, 1981, Comparison of metastasis of mammary tumors growing in the mammary fat pad versus subcutis.Invasion and Metastasis,1, 220–226.

    Google Scholar 

  28. Chambers AF, Colella R, Denhardt DT and Wilson SM, 1992, Increased expression of cathepsins L and B and decreased expression of their inhibitor in metastatic,ras-transformed NIH 3T3 cells.Molecular Carcinogenesis,5, 238–245.

    Google Scholar 

  29. Denhardt DT, Greenberg AH, Egan SE, Hamilton RT and Wright JA, 1987, Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts.Oncogene,2, 55–59.

    Google Scholar 

  30. Bevilacqua G, Sobel ME, Liotta LA and Steeg PS, 1989, Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas wih lymph node involvement and other histopathological indicators of high metastatic potential.Cancer Research,49, 5185–5190.

    Google Scholar 

  31. Haut M, Steeg P, Willson J and Markowitz S, 1991, Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential.Journal of the National Cancer Institute,83, 712–716.

    Google Scholar 

  32. Lacombe ML, Sastre-Garau X, Lascu I, Vonica A, Wallet V, Thiery JP and Veron M, 1991, Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumors.European Journal of Cancer,27, 1302–1307.

    Google Scholar 

  33. Dearolf C, Hersperger E and Shearn A, 1988, Developmental consequences ofawdb3, a cell-autonomous lethal mutation ofDrosophila induced by hybrid dysgenesis.Developmental Biology,129, 159–168.

    Google Scholar 

  34. Rosengard A, Krutzsch H, Shearn A, Biggs J, Barker E, Margulies I, King C, Liotta L and Steeg P, 1989, ReducedNm23/Awd protein in tumor metastasis and aberrantDrosophila development.Nature,342, 177–180.

    Google Scholar 

  35. Steeg PS, Cohn KH and Leone A, 1991, Tumor metastasis and nm23: current concepts.Cancer Cells,3, 257–262.

    Google Scholar 

  36. Craig A and Denhardt D, 1991, The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and inductionin vivo by estrogen and progesterone.Gene,100, 163–171.

    Google Scholar 

  37. Craig AM, Smith JH and Denhardt DT, 1989, Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetrade canoylphorbol-13-acetate in mouse epidermis.Journal of Biological Chemistry,264, 9682–9689.

    Google Scholar 

  38. Oldberg A, Franzen A and Heinegard D, 1986, Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence.Proceedings of the National Academy of Sciences,83, 8819–8823.

    Google Scholar 

  39. Prince CW, Oosawa T, Butler WT, Tomana M, Bhown AS and Schrohenloher RE, 1987, Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone.Journal of Biological Chemistry,262, 2900–2907.

    Google Scholar 

  40. Mark MP, Prince CW, Gay S, Austin RL and Butler WR, 1987, Immunohistochemical demonstration of a 44-kd phosphoprotein in developing rat bones.Journal of Histochemistry and Cytochemistry,35, 707–715.

    Google Scholar 

  41. Nomura S, Wills AJ, Edwards DR, Heath JK and Hogan BL, 1988, Developmental expression of tar (osteopontin) and SPARC (osteopontin) RNA as revealed byin situ hybridization.Journal of Cell Biology,106, 441–450.

    Google Scholar 

  42. Waterhouse P, Parhar RS, Guo X, Lala PK and Denhardt DT, 1992, Regulated temporal and spatial expression of the calcium-binding proteins calcyclin and OPN (osteopontin) in mouse tissues during pregnancy.Molecular Reproduction and Development,32, 315–323.

    Google Scholar 

  43. Chambers AF, Behrend EI, Wilson SM and Denhardt DT, 1992, Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic,ras-transformed NIH 3T3 cells.Anticancer Research,12, 43–48.

    Google Scholar 

  44. Senger DR, Asch BB, Smith BD, Perruzzi CA and Dvorak HF, 1983, A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells.Nature,302, 714–715.

    Google Scholar 

  45. Senger D, Perruzzi CA and Papadopoulos A, 1989, Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation.Anticancer Research,9, 1291–1300.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology and Immunology, University of Western Ontario, N6A SC1, London, Ontario, Canada

    Vincent L. Morris & Ann F. Chambers

  2. Department of Oncology, University of Western Ontario, N6A SC1, London, Ontario, Canada

    Alan B. Tuck, Sylvia M. Wilson & Ann F. Chambers

  3. London Regional Cancer Centre, N6A 4L6, London, Ontario, Canada

    Ann F. Chambers

  4. Department of Pathology, University of Guelph, N1 G 2W1, Guelph, Ontario, Canada

    Dean Percy

Authors
  1. Vincent L. Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alan B. Tuck
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sylvia M. Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dean Percy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ann F. Chambers
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morris, V.L., Tuck, A.B., Wilson, S.M. et al. Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines. Clin Exp Metast 11, 103–112 (1993). https://doi.org/10.1007/BF00880071

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00880071

Keywords

Search

Navigation